Article
A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance.
The Journal of experimental medicine - 2 Aug 2021
Warshauer Jeremy T, Belk Julia A, Chan Alice Y, Wang Jiaxi, Gupta Alexander R, Shi Quanming, Skartsis Nikolaos, Peng Yani, Phipps Jonah D, Acenas Dante, Smith Jennifer A, Tamaki Stanley J, Tang Qizhi, Gardner James M, Satpathy Ansuman T, Anderson Mark S
Abstract excerpt
Naturally occurring cases of monogenic type 1 diabetes (T1D) help establish direct mechanisms driving this complex autoimmune disease. A recently identified de novo germline gain-of-function (GOF) mutation in the transcriptional regulator STAT3 was found to cause neonatal T1D. We engineered a novel knock-in mouse incorporating this highly diabetogenic human STAT3 mutation (K392R) and found that these mice...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
